Who owns BRIDGEBIO ONCOLOGY THERAPEUT?
- CUSIP Number: 107924102
Tip: Access positions for across all investors
Analyze quarterly positions in Bridgebio Oncology Therapeut with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Bridgebio Oncology Therapeut stock
Who bought or sold BRIDGEBIO ONCOLOGY THERAPEUT this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Cormorant Asset Management | 18M | $207M | 100% | Sep 2025 |
|
| Deerfield Management Company | 4.9M | $57M | 100% | Sep 2025 |
|
| Omega Fund Management | 3.3M | $38M | 100% | Sep 2025 |
|
| Wellington Management Company | 3.0M | $34M | 100% | Sep 2025 |
|
| Alphabet | 2.8M | $33M | 100% | Sep 2025 |
|
| EcoR1 Capital | 2.8M | $33M | 100% | Sep 2025 |
|
| Enavate Sciences GP | 2.6M | $30M | 100% | Sep 2025 |
|
| Citadel Advisors | 2.5M | $29M | 100% | Sep 2025 |
|
| BlackRock | 2.0M | $24M | 100% | Sep 2025 |
|
| Novo A/S | 2.0M | $23M | 100% | Sep 2025 |
|
| Paradigm Biocapital Advisors | 1.9M | $22M | 100% | Sep 2025 |
|
| Adage Capital Partners GP | 1.5M | $17M | 100% | Sep 2025 |
|
| Eventide Asset Management | 1.1M | $12M | 100% | Sep 2025 |
|
| Laurion Capital Management | 1.0M | $12M | 100% | Sep 2025 |
|
| Octagon Capital Advisors | 1.0M | $12M | 100% | Sep 2025 |
|
| Vanguard Group | 648k | $7.5M | 100% | Sep 2025 |
|
| Aisling Capital Management | 565k | $6.5M | 100% | Sep 2025 |
|
| Geode Capital Management | 542k | $6.3M | 100% | Sep 2025 |
|
| ADAR1 Capital Management | 501k | $5.8M | 100% | Sep 2025 |
|
| Silverarc Capital Management | 457k | $5.3M | 100% | Sep 2025 |
|
| Armistice Capital | 412k | $4.8M | 100% | Sep 2025 |
|
| Millennium Management | 370k | $4.1M | 100% | Sep 2025 |
|
| Casdin Capital | 282k | $3.3M | 100% | Sep 2025 |
|
| Charles Schwab Investment Management | 279k | $3.2M | 100% | Sep 2025 |
|
| Ikarian Capital | 245k | $2.8M | 100% | Sep 2025 |
|
| Stempoint Capital | 187k | $2.2M | 100% | Sep 2025 |
|
| State Street Corporation | 177k | $2.0M | 100% | Sep 2025 |
|
| FMR | 162k | $1.9M | 100% | Sep 2025 |
|
| Sio Capital Management | 131k | $1.5M | 100% | Sep 2025 |
|
| TD Asset Management | 130k | $1.5M | 100% | Sep 2025 |
|
| Woodline Partners | 104k | $1.2M | 100% | Sep 2025 |
|
| Moore Capital Management | 100k | $1.2M | 100% | Sep 2025 |
|
| Boothbay Fund Management | 97k | $1.1M | 100% | Sep 2025 |
|
| Northern Trust | 96k | $1.1M | 100% | Sep 2025 |
|
| UBS Group | 52k | $605k | 100% | Sep 2025 |
|
| XTX Topco | 23k | $271k | 100% | Sep 2025 |
|
| China Universal Asset Management | 5.0k | $58k | 100% | Sep 2025 |
|
| Royal Bank of Canada | 16.00 | $0 | 100% | Sep 2025 |
|